Subscribe to Newsletter
Diagnostics Analytical science, Microscopy and imaging

Instant Raman

Approximately one in every 200 people have inflammatory bowel disease (IBD) (1). For sufferers, it’s not just the pain and indignity of some of the disease’s characteristic symptoms (abdominal pain, weight loss, diarrhea), there is also an increased risk of gastrointestinal cancer – so appropriate disease management is key. To effectively treat the condition, it’s important to correctly diagnose the subtype – ulcerative colitis (UC) or Crohn’s disease (CD) – but an overlap in symptoms makes the task difficult. In fact, there is only one (significantly invasive) way to avoid diagnostic uncertainty: colon biopsy (2).

In the past, researchers have investigated less invasive techniques such as laser endomicroscopy or MRI. Unfortunately, these methods focus on structural tissue changes, which are caused by IBD rather than being a symptom of it, making disease diagnosis less accurate.

Could Raman spectroscopy offer an effective in vivo alternative? A team of researchers led by Anita Mahadevan- Jansen decided that it was worth a shot (2). By coupling the technique with a fiber-optic probe, they created a real-time, minimally invasive tool to characterize the spectral signatures of IBD, reaching 90 percent sensitivity and 75 specificity to CD. The method was also able to determine the severity of the disease.

By striking a balance between diagnostic accuracy and patient safety and comfort, the new tool could be an important first step toward a minimally-invasive, realtime clinical diagnostic for IBD.

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. GG Kaplan, “The global burden of IBD: from 2015 to 2025”, Nat Rev Gastroenterol Hepatol, 12, 720-727 (2015). PMID: 26323879.
  2. IJ Pence et al., “Clinical characterization of in vivo inflammatory bowel disease with Raman spectroscopy”, Biomed Opt Express, 8, 524-535 (2017).
About the Author
William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine